• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Retrospective Detection of SARS-CoV-2 in Symptomatic Patients prior to Widespread Diagnostic Testing in Southern California

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2021 May 3;ciab360.
doi: 10.1093/cid/ciab360. Online ahead of print.
Retrospective Detection of SARS-CoV-2 in Symptomatic Patients prior to Widespread Diagnostic Testing in Southern California


Evann E Hilt[SUP] 1 [/SUP], James Boocock[SUP] 2 3 4 [/SUP], Marisol Trejo[SUP] 1 [/SUP], Catherine Q Le[SUP] 1 [/SUP], Longhua Guo[SUP] 2 3 4 [/SUP], Yi Zhang[SUP] 2 [/SUP], Laila Sathe[SUP] 1 [/SUP], Valerie A Arboleda[SUP] 1 2 [/SUP], Yi Yin[SUP] 2 [/SUP], Joshua S Bloom[SUP] 2 3 [/SUP], Pin-Chieh Wang[SUP] 5 [/SUP], Joann G Elmore[SUP] 5 [/SUP], Leonid Kruglyak[SUP] 2 3 4 [/SUP], Lasata Shrestha[SUP] 6 [/SUP], Shah A Mohamed Bakhash[SUP] 6 [/SUP], Michelle Lin[SUP] 6 [/SUP], Hong Xie[SUP] 6 [/SUP], Meei-Li Huang[SUP] 6 [/SUP], Pavitra Roychoudhury[SUP] 6 [/SUP], Alexander Greninger[SUP] 6 [/SUP], Sukantha Chandrasekaran[SUP] 1 [/SUP], Shangxin Yang[SUP] 1 [/SUP], Omai B Garner[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused one of the worst pandemics in recent history. Few reports have revealed that SARS-CoV-2 was spreading in the United States as early as the end of January. In this study, we aimed to determine if SARS-CoV-2 had been circulating in the Los Angeles (LA) area at a time when access to diagnostic testing for coronavirus disease 2019 (COVID-19) was severely limited.
Methods: We used a pooling strategy to look for SARS-CoV-2 in remnant respiratory samples submitted for regular respiratory pathogen testing from symptomatic patients from November 2019 to early March 2020. We then performed sequencing on the positive samples.
Results: We detected SARS-CoV-2 in 7 specimens from 6 patients, dating back to mid-January. The earliest positive patient, with a sample collected on January 13, 2020 had no relevant travel history but did have a sibling with similar symptoms. Sequencing of these SARS-CoV-2 genomes revealed that the virus was introduced into the LA area from both domestic and international sources as early as January.
Conclusions: We present strong evidence of community spread of SARS-CoV-2 in the LA area well before widespread diagnostic testing was being performed in early 2020. These genomic data demonstrate that SARS-CoV-2 was being introduced into Los Angeles County from both international and domestic sources in January 2020.

Keywords: Diagnostic Testing; SARS-CoV-2.
 
Back
Top Bottom